<DOC>
	<DOCNO>NCT01841476</DOCNO>
	<brief_summary>Phase I study determine compare safety/tolerability single ascending dos POL6326 intravenous infusion .</brief_summary>
	<brief_title>Safety Efficacy POL6326 Mobilization Hematopoietic Stem Cells Healthy Volunteers</brief_title>
	<detailed_description>Phase I Study - determine compare safety single ascending dos POL6326 intravenous infusion - determine relationship 2-hour single intravenous infusion dos POL6326 concentration HSC mature WBC peripheral blood use immunophenotypic assay .</detailed_description>
	<criteria>1 . Mobilization collection hematopoietic stem cell ( HSCs ) use GCSF least 6 week less 6 month prior protocol enrollment . 2 . Ages great equal 18 year less equal 55 year . 3 . Normal liver renal function , normal CBC , normal ECG , normal blood pressure include adequately medically control idiopathic arterial hypertension , contraindication mobilize peripheral blood stem cell donation accord WMDA criterion relevant SOPs study site define additional exclusion criterion stem cell donation . 4 . Subject must eligible normal blood donation accord requirement IDMs lay national law blood donor . 5 . Ability comprehend investigational nature study provide inform consent . 1 . Active infection history recurrent infection hepatitis B C ( HBsAg , AntiHBc , AntiHCV ) , HIV HTLV1 . 2 . History autoimmune disease rheumatoid arthritis , systemic lupus erythematous . 3 . History cancer within past 5 year exclude basal cell squamous cell carcinoma skin . 4 . History hematologic disorder include thromboembolic disease . 5 . History cardiac disease uncontrolled hypertension , peripheral vascular disease , myocardial infarction , cardiac arrhythmia OR relate symptom tachycardia , chest pain , shortness breath require medical intervention OR treatment Framingham coronary disease risk prediction score great 10 % 10 year coronary heart disease ( CHD ) risk .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Peripheral blood</keyword>
	<keyword>HSC</keyword>
	<keyword>Mobilization</keyword>
	<keyword>CXCR4</keyword>
	<keyword>volunteer</keyword>
</DOC>